Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study

Date issued
2014Journal title
Journal Of Clinical Oncology
Type of content
Publicación de congreso
